Acadia Healthcare Stock Forecast, Price & News

Acadia Healthcare (NASDAQ:ACHC) Frequently Asked Questions

Is Acadia Healthcare a buy right now?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Acadia Healthcare in the last year. There are currently 1 sell rating, 6 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Acadia Healthcare stock.
View analyst ratings for Acadia Healthcare or view top-rated stocks.

What stocks does MarketBeat like better than Acadia Healthcare?

Wall Street analysts have given Acadia Healthcare a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Acadia Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Acadia Healthcare's next earnings date?

Acadia Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, October 28th 2021.
View our earnings forecast for Acadia Healthcare.

How can I listen to Acadia Healthcare's earnings call?

Acadia Healthcare will be holding an earnings conference call on Friday, October 29th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Acadia Healthcare's earnings last quarter?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) announced its quarterly earnings data on Sunday, August, 1st. The company reported $0.71 EPS for the quarter, beating the Zacks' consensus estimate of $0.63 by $0.08. The company earned $582.20 million during the quarter, compared to analyst estimates of $560.88 million. Acadia Healthcare had a negative net margin of 27.61% and a positive trailing twelve-month return on equity of 11.70%. The company's revenue was up 18.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.54 earnings per share.
View Acadia Healthcare's earnings history.

How has Acadia Healthcare's stock price been impacted by Coronavirus (COVID-19)?

Acadia Healthcare's stock was trading at $23.40 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ACHC stock has increased by 141.6% and is now trading at $56.53.
View which stocks have been most impacted by COVID-19.

What guidance has Acadia Healthcare issued on next quarter's earnings?

Acadia Healthcare updated its FY 2021 earnings guidance on Monday, August, 9th. The company provided earnings per share (EPS) guidance of $2.500-$2.700 for the period, compared to the Thomson Reuters consensus estimate of $2.450. The company issued revenue guidance of $2.28 billion-$2.32 billion, compared to the consensus revenue estimate of $2.27 billion.

What price target have analysts set for ACHC?

15 analysts have issued twelve-month target prices for Acadia Healthcare's stock. Their forecasts range from $42.00 to $85.00. On average, they anticipate Acadia Healthcare's stock price to reach $66.79 in the next twelve months. This suggests a possible upside of 18.1% from the stock's current price.
View analysts' price targets for Acadia Healthcare or view top-rated stocks among Wall Street analysts.

Who are Acadia Healthcare's key executives?

Acadia Healthcare's management team includes the following people:

• Debra Kay Osteen, Chief Executive Officer & Director
• John S. Hollinsworth, Executive Vice President-Operations
• David M. Duckworth, Chief Financial Officer
• Michael V. Genovese, Chief Medical Officer
• Anne Kelly, Chief Quality & Compliance Officer

What is Debra K. Osteen's approval rating as Acadia Healthcare's CEO?

41 employees have rated Acadia Healthcare CEO Debra K. Osteen on Glassdoor.com. Debra K. Osteen has an approval rating of 36% among Acadia Healthcare's employees. This puts Debra K. Osteen in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Acadia Healthcare's key competitors?

Some companies that are related to Acadia Healthcare include HCA Healthcare (HCA), Alcon (ALC), Universal Health Services (UHS), Encompass Health (EHC), Tenet Healthcare (THC), Petco Health and Wellness (WOOF), Select Medical (SEM), The Ensign Group (ENSG), Community Health Systems (CYH), U.S. Physical Therapy (USPH), Brookdale Senior Living (BKD), National HealthCare (NHC), Five Star Senior Living (FVE) and Capital Senior Living (CSU).
View all of ACHC's competitors.

What other stocks do shareholders of Acadia Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acadia Healthcare investors own include Chipotle Mexican Grill (CMG), Endologix (ELGX), American Airlines Group (AAL), Archer-Daniels-Midland (ADM), (APA), Athabasca Oil (ATH), Aegean Marine Petroleum Network (ANW), Broadcom (AVGO), Exxon Mobil (XOM) and Colfax (CFX).

What is Acadia Healthcare's stock symbol?

Acadia Healthcare trades on the NASDAQ under the ticker symbol "ACHC."

Who are Acadia Healthcare's major shareholders?

Acadia Healthcare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Hodges Capital Management Inc. (0.15%), Genesee Capital Advisors LLC (0.04%), Louisiana State Employees Retirement System (0.03%), Shilanski & Associates Inc. (0.02%), Pacer Advisors Inc. (0.02%) and Thompson Investment Management Inc. (0.01%).
View institutional ownership trends for Acadia Healthcare.

Which institutional investors are selling Acadia Healthcare stock?

ACHC stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., Symmetry Partners LLC, Thompson Investment Management Inc., and Louisiana State Employees Retirement System.
View insider buying and selling activity for Acadia Healthcare or view top insider-selling stocks.

Which institutional investors are buying Acadia Healthcare stock?

ACHC stock was bought by a variety of institutional investors in the last quarter, including Hodges Capital Management Inc., Genesee Capital Advisors LLC, Three Peaks Capital Management LLC, CAPROCK Group Inc., Shilanski & Associates Inc., Level Four Advisory Services LLC, and Wedge Capital Management L L P NC.
View insider buying and selling activity for Acadia Healthcare or or view top insider-buying stocks.

How do I buy shares of Acadia Healthcare?

Shares of ACHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Acadia Healthcare's stock price today?

One share of ACHC stock can currently be purchased for approximately $56.53.

How much money does Acadia Healthcare make?

Acadia Healthcare has a market capitalization of $5.08 billion and generates $2.09 billion in revenue each year. The company earns $-672.13 million in net income (profit) each year or $2.78 on an earnings per share basis.

How many employees does Acadia Healthcare have?

Acadia Healthcare employs 35,400 workers across the globe.

What is Acadia Healthcare's official website?

The official website for Acadia Healthcare is www.acadiahealthcare.com.

Where are Acadia Healthcare's headquarters?

Acadia Healthcare is headquartered at 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067.

How can I contact Acadia Healthcare?

Acadia Healthcare's mailing address is 6100 TOWER CIRCLE SUITE 1000, FRANKLIN TN, 37067. The company can be reached via phone at (615) 861-6000.